The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation models. Pfizer and Boltz have announced a collaboration aimed at expanding the ...
Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the former's historical data "to create state-of-the-art, exclusive models for ...
Boltz has raised $28 million in fresh funding while entering a strategic partnership with Pfizer that underscores the accelerating push by major drugmakers to embed artificial intelligence deeper into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results